Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar padparadsha (< 20) Submitted: 7/1/2008 3:35:50 AM : Outperform Start Price: $4.25 TCM Score: -3.27

Panic panic, bargains galore

Featured Broker Partners


Advertisement